Humanin variant P3S is associated with longevity in APOE4 carriers and resists APOE4 ‐induced brain pathology
Aging Cell · 2024
DOI: 10.1111/acel.14153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2024. Verfasst von Brendan Miller und 16 weiteren Autor:innen. Beteiligte Einrichtung: Leonard Davis School of Gerontology, University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Apolipoprotein E4, Brain, Longevity. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute on Aging - National Institutes of Health (NIH), NIA NIH HHS, NIH HHS.
Abstract (Originalsprache)
The APOE4 allele is recognized as a significant genetic risk factor to Alzheimer's disease (AD) and influences longevity. Nonetheless, some APOE4 carriers exhibit resistance to AD even in advanced age. Humanin, a mitochondrial‐derived peptide comprising 24 amino acids, has variants linked to cognitive resilience and longevity. Our research uncovered a unique humanin variant, P3S, specifically enriched in centenarians with the APOE4 allele. Through in silico analyses and subsequent experimental validation, we demonstrated a strong affinity between humanin P3S and APOE4 . Utilizing an APOE4 ‐centric mouse model of amyloidosis (APP/PS1/ APOE4 ), we observed that humanin P3S significantly attenuated brain amyloid‐beta accumulation compared to the wild‐type humanin. Transcriptomic assessments of mice treated with humanin P3S highlighted its potential mechanism involving the enhancement of amyloid beta phagocytosis. Additionally, in vitro studies corroborated humanin P3S's efficacy in promoting amyloid‐beta clearance. Notably, in the temporal cortex of APOE4 carriers, humanin expression is correlated with genes associated with phagocytosis. Our findings suggest a role of the rare humanin variant P3S, especially prevalent among individuals of Ashkenazi descent, in mitigating amyloid beta pathology and facilitating phagocytosis in APOE4 ‐linked amyloidosis, underscoring its significance in longevity and cognitive health among APOE4 carriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leonard Davis School of Gerontology, University of Southern California, Los Angeles, California, USA.
- Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA.
- Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
- Department of Medicine (Geriatrics), Duke University Medical Center, Durham, North Carolina, USA.
- Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
- Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
ORCID-Profile: Brendan Miller, Nilüfer Ertekin-Taner
Förderung
- National Institute on Aging - National Institutes of Health (NIH)
- NIA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Miller, B., Kim, S. J., Cao, K., Mehta, H. H., Thumaty, N., Kumagai, H., Iida, T., McGill, C., Pike, C. J., Nurmakova, K., Levine, Z. A., Sullivan, P. M., Yen, K., Ertekin-Taner, N., Atzmon, G., Barzilai, N., & Cohen, P. (2024). Humanin variant P3S is associated with longevity in APOE4 carriers and resists APOE4 ‐induced brain pathology. Aging Cell. https://doi.org/10.1111/acel.14153
Vancouver
Miller B, Kim SJ, Cao K, Mehta HH, Thumaty N, Kumagai H, et al. Humanin variant P3S is associated with longevity in APOE4 carriers and resists APOE4 ‐induced brain pathology. Aging Cell. 2024. doi:10.1111/acel.14153
BibTeX
@article{Miller2024,
author = {Miller, Brendan and Kim, Su-Jeong and Cao, Kevin and Mehta, Hemal H and Thumaty, Neehar and Kumagai, Hiroshi and Iida, Tomomitsu and McGill, Cassandra and Pike, Christian J and Nurmakova, Kamila and Levine, Zachary A and Sullivan, Patrick M and Yen, Kelvin and Ertekin-Taner, Nilüfer and Atzmon, Gil and Barzilai, Nir and Cohen, Pinchas},
title = {Humanin variant P3S is associated with longevity in APOE4 carriers and resists APOE4 ‐induced brain pathology},
journal = {Aging Cell},
year = {2024},
doi = {10.1111/acel.14153}
}
EUVIMED